# Patch Testing Under Biologics: Six Cases From a Tertiary Centre

**Authors:** Alessandra Chiei‐Gallo, Francesca Barei, Angelo V. Marzano, Silvia M. Ferrucci

PMC · DOI: 10.1111/cod.70065 · 2025-12-14

## Full-text entities

- **Genes:** IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** type IV delayed-type) hypersensitivity (MESH:D006968), Crohn's disease (MESH:D003424), ACD (MESH:D017449), psoriasis (MESH:D011565), psoriatic arthritis (MESH:D015535), benign prostatic hyperplasia (MESH:D011470), urticaria (MESH:D014581), inflammatory (MESH:D007249), HS (MESH:D017497)
- **Chemicals:** gold sodium thiosulfate (MESH:D012971), cobalt (MESH:D003035), nickel sulphate (MESH:C029938), Guselkumab (MESH:C000588857), gold (MESH:D006046), cobalt chloride (MESH:C018021), povidone (MESH:D011205), chromium (MESH:D002857), hydroxypropyl cellulose (MESH:C008079), Adalimumab (MESH:D000068879), Risankizumab (MESH:C000601773), sodium thiosulfate (MESH:C017717), potassium bichromate (MESH:D011192), Bimekizumab (MESH:C000625981)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12872334